Vise Technologies’s Novo Nordisk NVO Stock Holding History

Vise Technologies’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Hold	35,214	–	–	0.04%	404
2025 Q4	$1.79M	Buy	35,214 +8,485	+32%	+$434K	0.04%	405
2025 Q3	$1.48M	Sell	26,729 -403	-1%	-$23.6K	0.06%	325
2025 Q2	$1.87M	Buy	+27,132	New	+$1.85M	0.08%	278
2024 Q4	$1.76M	Buy	20,443 +862	+4%	+$93.2K	0.15%	148
2024 Q3	$2.33M	Sell	19,581 -652	-3%	-$87K	0.3%	74
2024 Q2	$2.89M	Buy	20,233 +519	+3%	+$68.8K	0.51%	42
2024 Q1	$2.53M	Sell	19,714 -641	-3%	-$76.3K	0.5%	45
2023 Q4	$2.11M	Buy	20,355 +927	+5%	+$91.7K	0.45%	56
2023 Q3	$1.77M	Sell	19,428 -518	-3%	-$45.6K	0.43%	54
2023 Q2	$1.61M	Buy	19,946 +1,104	+6%	+$90.2K	0.39%	61
2023 Q1	$1.5M	Buy	18,842 +1,090	+6%	+$77.3K	0.4%	59
2022 Q4	$1.2M	Buy	17,752 +2,044	+13%	+$120K	0.38%	58
2022 Q3	$782K	Buy	15,708 +910	+6%	+$48.7K	0.29%	73
2022 Q2	$824K	Buy	14,798 +7,418	+101%	+$412K	0.32%	73
2022 Q1	$410K	Buy	+7,380	New	+$379K	0.15%	139

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Vise Technologies's NVO Position: Q1 2026 in Review

Vise Technologies held its Novo Nordisk (NVO) position steady in Q1 2026 at 35,214 shares worth $1.79M. The position accounts for 0.04% of the portfolio, ranked #404.

Vise Technologies first reported a position in NVO in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.89M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Vise Technologies held 35,214 shares of Novo Nordisk worth $1.79M as of Q1 2026.
Vise Technologies left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up 0.04% of Vise Technologies's portfolio in Q1 2026, its #404 holding.
Vise Technologies first reported a position in Novo Nordisk in Q1 2022 and has held it in 16 quarters since.
Vise Technologies's Novo Nordisk position peaked at $2.89M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.